logo
Sunscreens and hormone health: What you should know before you apply

Sunscreens and hormone health: What you should know before you apply

India Today2 days ago

As the summer continues to blaze and skin protection becomes a daily essential, growing questions around sunscreen ingredients and their potential long-term health impacts are starting to surface.Recent studies and international safety reviews have highlighted concerns about certain chemical ingredients commonly used in sunscreens, particularly their ability to be absorbed into the bloodstream and act as hormone disruptors.A hormone disruptor is a chemical that has the ability to cross cell membranes and interfere with the body's natural hormone production.advertisement
But dermatologists stress that this does not mean sunscreens are unsafe or should be avoided altogether.Rather, it's a reminder to be more informed about what we apply on our skin every day."The concern for safety and effectiveness of sunscreen ingredients has been heightened after recent evidence of their measurable systemic absorption following topical application," Dr. Sarita Sanke, dermatologist at Yashoda Super Speciality Hospitals, Kaushambi, told IndiaToday.in.Among the ingredients drawing attention are oxybenzone and octinoxate, two UV filters widely used for their ability to absorb harmful UVB and UVA rays of the sun.However, both have also been found in blood, urine, breast milk, and even amniotic fluid, raising questions about their possible impact on hormonal balance and foetal development.While these ingredients are not banned and continue to be approved for use in many countries, including India, doctors say more research is needed.advertisementThe US FDA (Food and Drugs Administration) has highlighted the importance of further evaluating all sunscreen ingredients with systemic absorption levels over 0.5 ng/mL, Dr. Sanke informed.DOES SUNSCREEN DISRUPT HOMONES?Some studies have pointed to possible associations with thyroid changes, pubertal development, kidney function, and immune health, though these findings remain inconclusive.Other ingredients under scrutiny include homosalate, avobenzone, octisalate, and octocrylene, all commonly found in many commercial sunscreen formulations and approved by the US FDA.However, the research is far from definitive.'Octinoxate and oxybenzone are also present in plastic packaging, water, air, and cosmetics. While detected in body fluids, their systemic exposure hasn't been proven harmful in humans,' said Bengaluru-based dermatologist Dr. Divya Sharma.She added that sunscreen safety is still under active investigation globally, but no regulatory agency has so far called for discontinuing their use.WHAT SHOULD CONSUMERS DO?Both Dr. Sanke and Dr. Sharma suggest that mineral sunscreens, which contain zinc oxide or titanium dioxide, could be a safer alternative for those concerned.These ingredients physically block UV rays rather than absorbing them, and while they too can penetrate the skin in small amounts, the current data do not indicate toxicity.In fact, many sunscreen formulations available in India have already phased out older ingredients like PABA and triethanolamine, which were previously linked to safety concerns.advertisementWhile some studies have raised concerns about sunscreen chemicals affecting fish microbiota and aquatic systems, no evidence yet links these effects to human health.Dermatologists advise that sunscreens are a critical defence against skin cancer and premature ageing, especially in a country like India where UV indices frequently soar.Avoiding sunscreen entirely out of fear would be misguided, doctors warn.Instead, the advice is to choose wisely, look at ingredient labels, and opt for mineral-based products where possible, particularly for children, pregnant women, or those with sensitive skin.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

₹1-crore health cover is fast becoming a necessity. But how to buy one?
₹1-crore health cover is fast becoming a necessity. But how to buy one?

Mint

time2 hours ago

  • Mint

₹1-crore health cover is fast becoming a necessity. But how to buy one?

In 2016, Hyderabad-based Ankur Pathak's mother-in-law was diagnosed with Stage-III ovarian cancer, barely a month or two after undergoing angioplasty. The back-to-back medical emergencies left the family with limited funds to manage the treatment costs. Though she had a reimbursement-based government health cover, the procedural delay and out-of-pocket expenses proved overwhelming. She passed away within three months, unable to continue chemotherapy. The experience made Pathak realize the importance of having a strong insurance cover with adequate immediate support, regardless of employer-provided plans. He opted for ₹50 lakh base coverage, which would increase to ₹1 crore with no-claim bonuses. Also Read: Health insurance vs medical corpus: What should senior citizens prioritize? More Indians are opting for ₹1-crore health covers as medical costs rise. Online insurance platform Policybazaar saw the number of such policies surge to 9,739 in 2024 from 4,427 policies in 2023. 'In 2025, we've already sold 7,521 such policies by May," said Siddharth Singhal, health insurance head at Policybazaar, noting an 85% growth expectation for the year. Why ₹1 crore? Insurance advisors say ₹1 crore may feel excessive today, but five to 10 years down the line, it could be just about right. Medical inflation is pushing costs up fast. Data from the surgery-care company Hexa Health showed that the average severe illness claim in India doubles every 10 years. For example, cancer treatment costs that hovered around ₹2-3 lakh in 2015 now average ₹4-6 lakh, and could touch ₹9 lakh by 2035. Meanwhile, a heart bypass that cost ₹3 lakh a decade ago may cost over ₹6 lakh by 2035. While average treatment costs for severe illnesses provide a baseline, actual expenses often run significantly higher, especially in private hospitals and metro cities, where charges can be 2-3X the national average. Additionally, illnesses rarely occur in isolation; follow-up treatments, diagnostics, and medications add recurring costs over time. One practical way to secure comprehensive coverage is to opt for a ₹1 crore base health insurance policy directly. Take Hyderabad-based Niraj Dugar, a 34-year-old financial planner who holds such a plan. He finds his annual premium of around ₹27,000 manageable, noting that insurers don't charge proportionally more for a significantly higher sum insured. For him, this coverage is essential, not just for today's hospital bills, which can run into lakhs for a single week's stay, but to stay ahead of relentless medical inflation. Before covid-19 hit, Bhumica Aggarwal's father, a businessman from Meerut, invested in a ₹1-crore policy, realizing the premium bump for higher coverage was 'not much'. Five years later, at 67, he happily renews it at ₹87,000 per year. Though claims have been minor, he values it as a critical 'safety net'. Also Read: Why health insurance during and after pregnancy is essential Preeti Zende, a Sebi-registered investment advisor, said a ₹1-crore cover is within reach for anyone with a disposable income of ₹1 lakh or more. To balance affordability, Zende advises gradually increasing coverage. But if one delays it too long, a sudden illness like cancer could prevent them from receiving upgrades. Why start early? 'Even if health issues arise, insurers are more likely to accommodate sum increases for existing policyholders, sometimes with a premium loading or waiting period, than accept fresh applications after diagnosis because getting coverage after it's detected is near impossible," said Zende. One of Zende's clients had opted for a ₹1-crore health cover, combining a base policy with a super top-up. When cancer was diagnosed, the coverage proved critical. Had they waited until after diagnosis, insurers would have outright rejected their application. One of the most popular ways to afford a ₹1-crore health cover is to combine a base policy with a super top-up plan. According to Policybazaar, 80% of its customers opt for a ₹10-lakh base policy paired with a ₹90-lakh super top-up combination compared to other combos. However, Zerodha-backed insurance advisory firm Ditto Insurance warned that while this combo keeps premiums low, super top-ups often come with conditions that can limit how much of the cover one actually uses. 'Super top-ups can have room rent or disease-wise limits. One must understand those conditions and avoid them if possible." If the base and super top-up dates don't align, one may also end up juggling two renewal dates and premium payments. Even so, for those prioritising affordability, this combo remains a go-to. Comprehensive coverage vs super top-ups Ditto Insurance has observed a recent shift: people with higher financial capacity are moving toward comprehensive health plans that automatically increase the sum insured each year, up to a certain cap. These plans often include loyalty bonuses, unlimited restoration benefits, and cover for consumables—benefits that in many cases offer better value than a super top-up. While these policies come at a slightly higher cost, many find them more straightforward and practical. This is what Pathak chose after his mother-in-law passed away. He paid a premium of ₹1.15 lakh for a three-year renewal this year. Starting 2024, insurers in India have come up with health plans that offer 'super bonus" features, typically as add-ons that boost your cover each year, sometimes up to an 'unlimited" sum insured. Priya Deshmukh, head of health products, operations and services at ICICI Lombard, explained that the Elevate plan's 'power booster" add-on 'provides 100% of cumulative bonus annually of the base sum insured every year on year with no cap, thus unlimited sum insured, regardless of whether a claim is made in the preceding year." Aditya Shah, founder of Hercules Insurance Advisors, called these the 'first option" for those targeting high coverage. When bought early, such plans can grow to ₹3-5 crore over the years. He suggested that a ₹1-crore health insurance policy may be unnecessary, due to the availability of newer 2024 plans with features like annual cover increases. Shah described such plans as more 'sustainable" long-term options compared to high-premium ₹1-crore covers, especially as premiums become unaffordable with age. However, Ditto pointed out that super bonus add-ons, especially those with unlimited accumulation, do not have the same level of security as a base plan does when it comes to lifelong renewability and pricing. There is a risk that insurers might increase the price of these add-ons significantly in the future if the claims associated with these benefits become unsustainable. Also Read: Not many claim mental healthcare insurance. Here's why In the case of the super bonus add-ons, especially those with unlimited accumulation, if you opt out of this cover at the time of renewal, all the bonuses accumulated under the power booster will be reduced to zero. What's the cost-effective way? Experts suggested gradually increasing the sum insured year after year. Next best is the popular base ( ₹10L) + super top-up ( ₹90L) combo—affordable but with hidden limits. Comprehensive plans with in-built increasing cover come third—pricier but packed with features. New 'unlimited growth" policies rank fourth—great on paper, but can be expensive in the long run. What's the simplest but most expensive option? Buying a full ₹1-crore base policy outright—smooth claims but heavy premiums. Vedant Vichare is a contributor to Mint.

Is India's Covid testing facing price gaps and delay in data?
Is India's Covid testing facing price gaps and delay in data?

India Today

time3 hours ago

  • India Today

Is India's Covid testing facing price gaps and delay in data?

India is seeing an uptick in Covid-19 infections, reaching over 7,000 cases. But in contrast to earlier waves, there seems to be gaps in diagnosis and the current season of rampant viral infections and many individuals showing symptoms, RT-PCR tests are neither being prescribed widely nor being voluntarily taken."Most of the Covid-19 testing we're seeing today is happening within hospitals, where viral panel testing is mandatory before procedures or in cases of severe symptoms. Neither clinicians nor patients are approaching it with the same urgency anymore," said Dr. Vibhu Kawatra, a Delhi-based pulmonologist and allergy RT-PCR (Reverse Transcription–Polymerase Chain Reaction), which remains the gold standard for detecting Covid-19, works by identifying the virus's genetic material in nasal or throat Dr. Kawatra pointed out, "Only a doctor can prescribe an RT-PCR test, and unless the symptoms are severe or hospitalisation is required, the test is often skipped."Even when testing is sought, accessibility and affordability are serious barriers. RT-PCR (Reverse Transcription–Polymerase Chain Reaction), which remains the gold standard for detecting Covid-19, works by identifying the virus's genetic material in nasal or throat samples. (Photo: AFP) In the private sector, RT-PCR test prices vary drastically depending on the diagnostic lab. Dr. Path Labs charges upwards of Rs 5,000 for a home collection, while Max Healthcare offers the same at Rs 500. At Dr. Dangs Lab, a home visit costs Rs 700. Similar price ranges are being seen across neighbourhood clinics as wide pricing disparity reflects the fragmented nature of the diagnostic sector, proving to be despite this inconsistent pricing model, there seems to be reduced testing rates, coupled with the closure of many free government testing centres.A recent visit to Lok Nayak Hospital in New Delhi revealed that the Covid testing window had been shut down. Many other government-run facilities have scaled back or completely discontinued RT-PCR testing, further limiting testing options for the general cases highlight the need for routine testing to monitor its spread."The patients who have died not just had Covid-19 but also had underlying health conditions. It is not always the virus alone, but the comorbidities that tip the scale," said Dr. Sudeep Khanna, gastroenterologist and liver specialist at Indraprastha Apollo IN VIRUS GENOMIC DATASurveillance at the national level is also facing Indian SARS-CoV-2 Genomics Consortium (INSACOG), the official body monitoring Covid-19 variants in India, has been slow in releasing updated epidemiological data. There seems to be reduced testing rates, coupled with the closure of many free government testing centres. () Only limited information has been shared so far for newer variants like LF.1, NB.1.8.1, and XFG, making it difficult to gauge the evolving nature of the health experts stress the need for proactive surveillance, affordable and accessible testing, and better data STOCKPILEGovernment sources told India Today that there are enough Covid-19 vaccines in storage and ready to use. "We are fully prepared for any situation. We have enough stockpile to meet the requirements of our citizens. Moreover, if needed, we can even supply vaccines to other countries," the sources 1 billion people in India have taken at least one dose of either Covishield or Covaxin. Only limited information has been shared so far for newer variants like LF.1, NB.1.8.1, and XFG, making it difficult to gauge the evolving nature of the virus. () Covishield, manufactured and distributed by the Serum Institute of India under a licence from AstraZeneca, stopped being produced in December 2021 because fewer people were taking Covaxin, India's first home-grown Covid-19 vaccine made by Bharat Biotech with ICMR-NIV, also stopped production in early the halt in manufacturing, officials say that vaccine availability is not a believe the current rise in cases may be due to seasonal changes in respiratory infections though global health experts say the protection from past infections and vaccines may be wearing off, which could be causing new spikes in some general information about Covid-19 continues to be available, there seems to be hindrances in the timely response to the InMust Watch

Are MRI scans safe? Top Hyderabad-based doctor wants you know 6 things before you step in
Are MRI scans safe? Top Hyderabad-based doctor wants you know 6 things before you step in

Time of India

time7 hours ago

  • Time of India

Are MRI scans safe? Top Hyderabad-based doctor wants you know 6 things before you step in

1. MRI scans are generally safe and radiation-free 2. They're highly accurate 3. But there are three common concerns to note — hyderabaddoctor (@hyderabaddoctor) 4. If you have metal in your body, consult your doctor 5. Kidney disease? Use contrast dye with caution 6. Pregnant women should weigh risks carefully In a world where diagnostic technology is advancing rapidly, MRI scans have become a go-to tool for everything from headaches to heart trouble. But just how safe are they, and are there hidden risks patients should be aware of? Dr. Sudhir Kumar , a Hyderabad-based neurologist, took to social media to break it all down in simple terms, offering crucial insights for anyone considering an what Dr. Kumar wants you to know:MRIs are widely used to diagnose neurological issues related to the brain and spine. They're also effective in identifying problems in the abdomen, heart, and other systems. Unlike CT scans or X-rays, MRI machines do not use radiation. That means no exposure risk during the procedure, one of the biggest advantages of MRI scans are both sensitive and specific, making them one of the most reliable tools for detecting and diagnosing a wide range of conditions. In many cases, they help doctors catch issues early and with great The enclosed space can trigger anxiety for some MRI machines are notoriously loud. While earplugs or headphones are usually provided, the sound can still be allergies: In rare cases, the dye (contrast) used to enhance images may trigger allergic with metallic implants, pacemakers, or cochlear devices should get medical clearance before scheduling an MRI. These devices may interfere with the scan or pose safety risks due to the strong magnetic with kidney problems need to be especially careful with contrast dyes. It's essential to consult a nephrologist before undergoing a contrast scans during pregnancy are not off-limits, but should be done only if the potential benefits outweigh any risks. Contrast dye should be avoided altogether, as it may negatively affect fetal development.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store